Implementing an Intravenous Insulin Protocol in Your Practice: Practical Advice to Overcome Clinical, Administrative, and Financial Barriers

Seminars in Thoracic and Cardiovascular Surgery

Volumn 18, Issue 4, 2006, Pages 346-358

  Kelly, Janet L ^a   Hirsch, Irl B ^a   Furnary, Anthony P ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

diabetes; economics; hyperglycemia; hypoglycemia; insulin

Indexed keywords

GLUCOSE; INSULIN;

ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL DECISION MAKING; CLINICAL PRACTICE; CLINICAL PROTOCOL; CONTINUOUS INFUSION; COST BENEFIT ANALYSIS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; CRITICALLY ILL PATIENT; DIABETES MELLITUS; DRUG COST; DRUG DOSE TITRATION; GLYCEMIC CONTROL; HOSPITAL COST; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN INFUSION; INTENSIVE CARE; LENGTH OF STAY; MEDICAL EDUCATION; MORTALITY; NURSE PATIENT RATIO; NURSING SHORTAGE; OPEN HEART SURGERY; PATIENT MONITORING; PATIENT SAFETY; PROGNOSIS; SURGICAL PATIENT;

CLINICAL PROTOCOLS; DIABETES MELLITUS; FINANCIAL MANAGEMENT, HOSPITAL; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INFUSIONS, INTRAVENOUS; INSULIN; MEDICAL STAFF, HOSPITAL; OREGON; PHYSICIAN'S PRACTICE PATTERNS; UNITED STATES;

EID: 33947573349     PISSN: 10430679     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semtcvs.2006.06.004     Document Type: Article

References (25)

1. Brown J.R., Edwards F.H., O'Connor G.T., et al. The Diabetic Disadvantage: Historical outcomes measures in diabetic patients undergoing cardiac surgery- the pre-intravenous insulin era. Sem Thorac Card Surg 18 (2006) 280-287
2. Capes S., Hunt D., Malmberg K., et al. Stress hyperglycemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 355 (2000) 773-778
3. Bolk J., van der Ploeg T., Cornel J.H., et al. Impaired glucose metabolism predicts mortality after a myocardial infarction. Int J Cardiol 79 (2001) 201-214
4. Umpierrez G.E., Isaacs S.D., Bazargan N., et al. Hyperglycemia: an independent marker of inhospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 87 (2002) 978-982
5. Furnary A., Zerr K., Grunkemeier G., et al. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg 67 (1999) 352-362
6. Furnary A.P., Gao G., Grunkemeier G.L., et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 125 (2003) 1007-1021
7. Capes S., Hunt D., Malmberg K., et al. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 32 (2001) 2426-2432
8. Malmberg K., Ryden L., Efendic S., et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study); effects on mortality at 1 year. J Am Coll Cardiol 26 (1995) 57-65
9. Van den Berghe G., Wouters P., Weekers F., et al. Intensive insulin therapy in critically ill patients. N Engl J Med 345 (2001) 1359-1367
10. Furnary A.P., Wu Y.X., et al. Eliminating the diabetic disadvantage: the Portland diabetic project. Sem Thorac Card Surg 18 (2006) 301-307
11. Vanhorebeek I., Ingels C., and Van den Berghe G. Intensive insulin therapy in high-risk cardiac surgery patients: evidence from the Leuven randomized study. Sem Thorac Card Surg 18 (2006) 308-315
12. Garber A.J., Moghissi E.S., Bransome E.D., et al. American College of Endocrinology position statement on inpatient diabetes and metabolic control. Endocr Pract 10 suppl 2 (2004) 4-9
13. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 28 suppl 2 (2005) S4-S34
14. Goldberg P.A., Siegel M.D., Sherwin R.S., et al. Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit. Diabetes Care 27 (2004) 461-467
15. Ku S.Y., Sayre C.A., Hirsch I.B., et al. New insulin infusion protocol improves blood glucose control in hospitalized patients without increasing hypoglycemia. Jt Comm J Qual Saf 31 (2005) 141-147
16. Markovitz L.J., Wiechmann R.J., Harris N., et al. Description and evaluation of a glycemic management protocol for patients with diabetes undergoing heart surgery. Endocr Pract 8 (2002) 10-18
17. Krinsley J.S. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc 79 (2004) 992-1000
18. Brvar M., Mozina M., and Bunc M. Prolonged hypoglycemia alter insulin lispro overdose. Eur J Emerg Med 12 (2005) 234-235
19. Tofade T.S., and Liles E.A. Intentional overdose with insulin glargine and insulin aspart. Pharmacotherapy 24 (2004) 1412-1418
20. Bubder C., Lauritzen T., Faber O., et al. Insulin pharmacokinetics. Diabetes Care 7 (1984) 188-199
21. Hirsch I.B. Insulin analogues. N Engl J Med 352 (2005) 174-183
22. Furnary A.P., Wu Y., and Bookin S.O. Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: the Portland Diabetic Project. Endocr Pract 10 suppl 2 (2004) 21-33
23. Krinsley J.S. Cost analysis of intensive glycemic control in critically ill adult patients. Chest 129 (2006) 644-650
24. Van den Berghe G., Wouters P.J., Kesteloot K., et al. Analysis of healthcare resource utilization with intensive insulin therapy in critically ill patients. Crit Care Med 34 (2006) 612-616
25. Lazar H.L., Chipkin S.R., Fitzgerald C.A., et al. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation 109 (2004) 1497-1502